Riario Sforza, G. G., Gentile, F., Stock, F., Caggiano, F., Chiocca, E., & Incorvaia, C. (2018). Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab. SAGE Open Med Case Rep.

Riario Sforza, Gian Galeazzo, Francesco Gentile, Fabio Stock, Francesco Caggiano, Enrica Chiocca, and Cristoforo Incorvaia. "Safety and Timing of Resuming Dabigatran After Major Gastrointestinal Bleeding Reversed By Idarucizumab." SAGE Open Med Case Rep 2018.

Riario Sforza, Gian Galeazzo, et al. "Safety and Timing of Resuming Dabigatran After Major Gastrointestinal Bleeding Reversed By Idarucizumab." SAGE Open Med Case Rep 2018.